ImmunoPrecise Antibodies (IPA) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts IPA Hot Sheet
Join SI Premium – FREE
ImmunoPrecise Antibodies (NASDAQ: IPA) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $6.98 million.
For earnings history and earnings-related data on ImmunoPrecise Antibodies (IPA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
